RecruitingNCT07001878
Cannabis strength and brain white matter in early psychosis
About this title
Read the official source — NCT07001878Medication studyAges 18–25CanadaSchizophrenia
Understand this study
Who could participate?
Listed age limits: 18 years to 25 years.
- Listed locations
- St. John's and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 18, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- Nova Scotia Health Authority
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 25 Years
- Official registry ID
- NCT07001878
- Official title
Show the full official title
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis: A Pilot Feasibility Treatment Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
St. John's · Halifax
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nova Scotia Health Authority.
Does this study involve medication?
Yes. The study involves medication, including Metformin.
Who can participate?
Listed age limits: 18 years to 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
